Blood Detection of EGFR Mutation For Iressa Treatment
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Gefitinib (Primary)
- Indications Lung cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms BENEFIT
- 18 Oct 2017 Results (n=152; data cut off: January 31, 2017) assessing efficacy presented at the 18th World Conference on Lung Cancer.
- 22 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Feb 2018.
- 22 Feb 2017 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2017.